Tri- and Tetrasubstituted Naphthalene Diimides for G-Quadruplex Stabilization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current anti-cancer agents based on naphthalene diimides have limited G-quadruplex binding ability and effectiveness, necessitating the development of improved compounds that can stabilize G-quadruplex regions in DNA and exhibit enhanced selectivity towards G-quadruplex over duplex DNA.
Innovation Solution
The development of novel tri- and tetrasubstituted naphthalene diimides with specific side chains that stabilize G-quadruplex regions in DNA, offering improved binding affinity and selectivity, which are synthesized using 2,6-dibromo- or 2,6-dichloro-1,4,5,8-naphthalene tetracarboxylic acid dianhydride as starting materials and characterized by their ability to form stable complexes with G-quadruplex structures.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If disubstituted naphthalene diimides are used as G-quadruplex ligands, then the compound structure is simpler and easier to synthesize, but the G-quadruplex binding affinity is limited
Solution Approach 1:
The patent changes the substitution degree parameter from disubstituted to tri- and tetrasubstituted naphthalene diimides, which increases the number of interaction points with G-quadruplex DNA and thereby enhances binding affinity while maintaining synthetic feasibility through established chemical routes
Solution Approach 2:
The patent creates composite molecular structures by combining naphthalene diimide core with multiple diverse substituent groups (including amine, carboxylic acid, and heterocyclic groups), which synergistically enhance G-quadruplex binding through multiple interaction mechanisms simultaneously
2Reliability
If naphthalene diimide compounds are designed to stabilize G-quadruplex regions, then anti-cancer effectiveness is improved, but selectivity between G-quadruplex and duplex DNA must be enhanced
Solution Approach 1:
The patent introduces specific functional groups at particular positions on the naphthalene diimide structure that are locally optimized for G-quadruplex recognition, creating distinct interaction characteristics that differentiate binding to G-quadruplex versus duplex DNA structures
Solution Approach 2:
The patent extends the molecular structure into additional spatial dimensions through bulky substituent groups that create a three-dimensional binding interface, enabling the compound to recognize the unique topology and surface features of G-quadruplex structures that are not present in duplex DNA
Data Source
AI summary
The invention relates to novel compounds which are naphthalene diimides of general formula (I). The compounds are used in therapy, particularly in cancer treatment.